BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8722708)

  • 61. Characterization of beta-adrenergic receptors in dispersed rat testicular interstitial cells.
    Poyet P; Labrie F
    J Androl; 1987; 8(1):7-13. PubMed ID: 3030990
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Characterization of specific binding sites for vasoactive intestinal peptide in rat intestinal epithelial cell membranes.
    Amiranoff B; Laburthe M; Rosselin G
    Biochim Biophys Acta; 1980 Jan; 627(2):215-24. PubMed ID: 7350925
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Molecular characteristics and evidence for internalization of vasoactive-intestinal-peptide (VIP) receptors in the tumoral rat-pancreatic acinar cell line AR 4-2 J.
    Svoboda M; De Neef P; Tastenoy M; Christophe J
    Eur J Biochem; 1988 Oct; 176(3):707-13. PubMed ID: 2844535
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Solubilization of the active vasoactive intestinal peptide receptor from human colonic adenocarcinoma cells.
    el Battari A; Martin JM; Luis J; Pouzol O; Secchi J; Marvaldi J; Pichon J
    J Biol Chem; 1988 Nov; 263(33):17685-9. PubMed ID: 2846575
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Stimulatory effect of vasoactive intestinal peptide (VIP) on cyclic AMP production in rat peritoneal macrophages.
    Segura JJ; Guerrero JM; Goberna R; Calvo JR
    Regul Pept; 1992 Feb; 37(3):195-203. PubMed ID: 1372999
    [TBL] [Abstract][Full Text] [Related]  

  • 66. High affinity vasoactive intestinal peptide receptors on fetal human nonpigmented ciliary epithelial cells.
    Crook RB; Lui GM; Alvarado JA; Fauss DJ; Polansky JR
    Curr Eye Res; 1994 Apr; 13(4):271-9. PubMed ID: 8033589
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Molecular identification of receptors for vasoactive intestinal peptide in rat intestinal epithelium by covalent cross-linking. Evidence for two classes of binding sites with different structural and functional properties.
    Laburthe M; Breant B; Rouyer-Fessard C
    Eur J Biochem; 1984 Feb; 139(1):181-7. PubMed ID: 6321173
    [TBL] [Abstract][Full Text] [Related]  

  • 68. VIP receptors in mesenteric and coronary arteries: a radioligand binding study.
    Huang M; Rorstad OP
    Peptides; 1987; 8(3):477-85. PubMed ID: 2821520
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Epithelial cells purified from choroid plexus have receptors for vasoactive intestinal polypeptide.
    Nilsson C; Fahrenkrug J; Lindvall-Axelsson M; Owman C
    Brain Res; 1991 Mar; 542(2):241-7. PubMed ID: 1851455
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Localisation and characterisation of functional vasoactive intestinal peptide receptors in feline kidney.
    Griffiths NM; Simmons NL
    Pflugers Arch; 1990 Apr; 416(1-2):80-7. PubMed ID: 2162036
    [TBL] [Abstract][Full Text] [Related]  

  • 71. High affinity peptide histidine isoleucine-preferring receptors in rat liver.
    Paul S; Chou J; Kubota E
    Life Sci; 1987 Nov; 41(21):2373-80. PubMed ID: 2824950
    [TBL] [Abstract][Full Text] [Related]  

  • 72. (-)[125I]iodopindolol binding to beta-adrenergic receptors in tissues of the rat with particular reference to the characterization in liver.
    Dax EM; Partilla JS; Jackson KL; Gregerman RI
    J Recept Res; 1986; 6(2):165-82. PubMed ID: 2873244
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Distribution and characterization of vasoactive intestinal polypeptide binding in canine lower esophageal sphincter.
    Mao YK; Wang YF; Daniel EE
    Gastroenterology; 1993 Nov; 105(5):1370-7. PubMed ID: 8224641
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Binding in vitro of vasoactive intestinal peptide on isolated acini of rat parotid glands.
    Dehaye JP; Christophe J; Ernst F; Poloczek P; Van Bogaert P
    Arch Oral Biol; 1985; 30(11-12):827-32. PubMed ID: 2421696
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Homologous regulation of vasoactive intestinal peptide (VIP) receptors on rat peritoneal macrophages.
    Pozo D; Guerrero JM; Calvo JR
    Peptides; 1995; 16(2):313-8. PubMed ID: 7784261
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Thymosin alpha 1 interacts with the VIP receptor-effector system in rat and mouse immunocompetent cells.
    Pozo D; Guerrero JM; Segura JJ; Calvo JR
    Immunopharmacology; 1996 Sep; 34(2-3):113-23. PubMed ID: 8886855
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Characterization and localization of atypical beta-adrenoceptors in rat ileum.
    Roberts SJ; Russell FD; Molenaar P; Summers RJ
    Br J Pharmacol; 1995 Nov; 116(6):2549-56. PubMed ID: 8590969
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Serotonergic and adrenergic regulation of skeletal muscle metabolism in the rat. II. The use of [125I]iodolysergic acid diethylamide and [125I]iodopindolol as probes of sarcolemmal receptor function and specificity.
    Moretti-Rojas I; Ezrailson EG; Birnbaumer L; Entman ML; Garber AJ
    J Biol Chem; 1983 Oct; 258(20):12499-508. PubMed ID: 6313663
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Elevation of intracellular cAMP by noradrenaline and vasoactive intestinal peptide in striated ducts isolated from the rabbit mandibular salivary gland.
    Evans RL; Perrott MN; Lau KR; Case RM
    Arch Oral Biol; 1996 Jul; 41(7):689-94. PubMed ID: 9015570
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Characterisation of a high-affinity VIP receptor in human lung parenchyma.
    Schachter M; Dickinson KE; Miles CM; Sever PS
    FEBS Lett; 1986 Apr; 199(1):125-9. PubMed ID: 3007215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.